Pharmacists to take on public health role

June 15, 2004

The government's drive to transform pharmacists into leading frontline healthcare professionals is to be spearheaded by a new consortium of …

Xenova’s cocaine vaccine shows promise

June 15, 2004

Cocaine addicts could be helped by a vaccine currently in development by UK biotech company Xenova, phase II results from …

Abbott buys heart drug from Aventis for $300 million

June 10, 2004

Chicago-based Abbott Laboratories has bought the marketing and manufacturing rights for cardiovascular drug trandolapril from Aventis, in a deal worth …

New schizophrenia drug Abilify gets European go-ahead

June 10, 2004

Abilify, Bristol-Myers Squibb and Otsuka's antipsychotic has received European Union marketing approval and will be promoted for having fewer side …

Lipitor halves stroke risk in diabetes patients

June 8, 2004

New Lipitor data suggests the drug cut the risk of stroke by half in diabetes patients, the compelling evidence potentially …

Shire relocates R&D headquarters to US

June 3, 2004

Shire Pharmaceuticals has relocated its research and development headquarters to the US as the company looks to increase its penetration …

Oxford BioMedica one step closer to Holy Grail of nerve damage

June 3, 2004

The promise of a gene-based technology which might one day cure spinal injuries and paralysis has moved one step closer …

PCT claims bullying over private contract

June 3, 2004

An NHS trust chairman has accused the government of bullying it into awarding a contract to a private firm, resulting …

Unmet needs in arthritis

June 3, 2004

Although there is no cure for rheumatoid arthritis (RA), a wide range of drugs are involved in its treatment. Similar …

CROs: flexible or overstretched?

June 3, 2004

If only I had known then what I know now about the labyrinthine world of Contract Research Organisations (CROs). This …

Counterfeit medicines on the rise

June 1, 2004

The World Health Organisation (WHO) estimates that up to 10% of medicines worldwide may be counterfeit, costing the pharmaceutical industry …

Making the most of your talent

May 27, 2004

The vast majority of pharma executives would argue that having a large number of products in any company's portfolio should …

Roche prescribing data to support NICE uptake

May 27, 2004

Roche is to provide NICE with regular updates on patient access to its treatments to help increase the uptake of …

The Gateway to Local Adoption Series

Latest content